Malatxeberria, Sefora External Entity

Publications

Sort by

Selected publications

  • Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible marker.  Oncotarget2016 Academic Article GET IT
    Times cited: 4

Other